Pancreatic stellate cells in the islets as a novel target to preserve the pancreatic β‐cell mass and function
Abstract There are numerous lines of clinical evidence that inhibition of the renin–angiotensin system (RAS) can prevent and delay the development of diabetes. Also, the role of RAS in the pathogenesis of diabetes, including insulin resistance and β‐cell dysfunction, has been extensively investigate...
Main Authors: | Yeoree Yang, Ji‐Won Kim, Heon‐Seok Park, Eun‐Young Lee, Kun‐Ho Yoon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Journal of Diabetes Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1111/jdi.13202 |
Similar Items
-
Screening and Identification of Key Genes for Activation of Islet Stellate Cell
by: Xiaohang Wang, et al.
Published: (2021-09-01) -
Activation and Regulation of Pancreatic Stellate Cells in Chronic Pancreatic Fibrosis: A Potential Therapeutic Approach for Chronic Pancreatitis
by: Fanyi Kong, et al.
Published: (2024-01-01) -
Pancreatic Stellate Cells and the Targeted Therapeutic Strategies in Chronic Pancreatitis
by: Man Chang, et al.
Published: (2023-07-01) -
Role of Pancreatic Stellate Cells in Chemoresistance in Pancreatic Cancer
by: Joshua eMcCarroll, et al.
Published: (2014-04-01) -
Pancreatic Stellate Cells and Metabolic Alteration: Physiology and Pathophysiology
by: Shin Hamada, et al.
Published: (2022-03-01)